α-Syn |
Alpha-synuclein |
AD |
Alzheimer’s disease |
Aβ |
Beta-amyloid |
BBB |
Blood–brain barrier |
CD |
Cluster of differentiation 14 |
CNS |
Central nervous system |
COX-2 |
Cyclooxygenase-2 |
CRP |
C-reactive protein |
CT51 |
Coumarin-tris hybrid |
DHC12 |
7,8-dihydroxycoumarin-12 |
Hgb |
Haemoglobin |
IFNγ |
Interferon-gamma |
IL |
Interleukin |
iNOS |
Inducible nitric oxide synthase |
LB |
Lewy body |
LPS |
Lipopolysaccharide |
LTA |
Lipoteichoic acid |
MRC |
Medical Research Council of South Africa |
mRNA |
Messenger ribonucleic acid |
MOA |
Monoamine oxidase |
NADPH |
Nicotinamide adenine dinucleotide phosphate reduced |
NF-кB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |
PARK |
Parkinson’s disease genes |
PD |
Parkinson’s disease |
RANTES |
Regulated upon activation, normal T cell expressed and presumably secreted |
REM |
Rapid eye movement |
Rgp |
Gingipain |
ROS |
Reactive oxygen species |
SAA |
Serum amyloid A |
SNc |
Substantia nigra pars compacta |
SUMO |
Small ubiquitin-like modifier |
TEM |
Transmission electron microscope |
TLR |
Toll-like receptor |
TNF-α |
Tumour necrosis factor-alpha |
TFN |
Transferrin |